Clinical Trial Update: Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the dose-response relationship of Botulinum toxin DWP-450 for finger flexor spasticity, sponsored by Seoul National Univ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity
• Stroke

Drugs mentioned

• DWP-450 (Nabota) (botulinum toxin type A)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Spasticity as Sequela of Stroke | Phase 4 | Status: UNKNOWN